Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting

Hdl Handle:
http://hdl.handle.net/10144/618951
Title:
Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting
Authors:
Ondiek, J; Namukaya, Z; Mtapuri-Zinyowera, S; Balkan, S; Elbireer, A; Ushiro Lumb, I; Kiyaga, C; Goel, N; Ritchie, A; Ncube, P; Omuomu, K; Ndiege, K; Kekitiinwa, A; Mangwanya, D; Fowler, Mary G; Nadala, L; Lee, H
Journal:
Journal of Acquired Immune Deficiency Syndromes (1999)
Abstract:
Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.
Publisher:
Lippincott Williams & Wilkins
Issue Date:
9-Jun-2017
URI:
http://hdl.handle.net/10144/618951
DOI:
10.1097/QAI.0000000000001476
PubMed ID:
28604503
Submitted date:
2017-06-26
Language:
en
ISSN:
1944-7884
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorOndiek, Jen
dc.contributor.authorNamukaya, Zen
dc.contributor.authorMtapuri-Zinyowera, Sen
dc.contributor.authorBalkan, Sen
dc.contributor.authorElbireer, Aen
dc.contributor.authorUshiro Lumb, Ien
dc.contributor.authorKiyaga, Cen
dc.contributor.authorGoel, Nen
dc.contributor.authorRitchie, Aen
dc.contributor.authorNcube, Pen
dc.contributor.authorOmuomu, Ken
dc.contributor.authorNdiege, Ken
dc.contributor.authorKekitiinwa, Aen
dc.contributor.authorMangwanya, Den
dc.contributor.authorFowler, Mary Gen
dc.contributor.authorNadala, Len
dc.contributor.authorLee, Hen
dc.date.accessioned2017-07-05T18:24:55Z-
dc.date.available2017-07-05T18:24:55Z-
dc.date.issued2017-06-09-
dc.date.submitted2017-06-26-
dc.identifier.citationMulti-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting. 2017 J. Acquir. Immune Defic. Syndr.en
dc.identifier.issn1944-7884-
dc.identifier.pmid28604503-
dc.identifier.doi10.1097/QAI.0000000000001476-
dc.identifier.urihttp://hdl.handle.net/10144/618951-
dc.description.abstractEarly diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.en
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en
dc.titleMulti-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Settingen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.